摘要
1例8岁男性患儿因特发性膜性肾病应用他克莫司(1.25 mg,1次/12 h)联合泼尼松(12.5 mg,隔日1次)口服治疗。5周后,患儿相继出现多饮、多尿、呕吐、嗜睡、脱水征。实验室检查:空腹葡萄糖22.4 mmol/L,动脉血酸碱度7.24,标准碳酸氢盐12 mmol/L,尿酮体(+++)。诊断为酮症酸中毒。停用他克莫司,给予静脉补液(2125 ml/d)及重组人胰岛素2.5 U/h持续静脉输注。10 h后血酸碱度7.40,空腹葡萄糖8.5 mmol/L,连续2次检测尿酮体均为阴性,改为三餐前皮下注射重组人胰岛素6.25 U。3周后,患儿空腹葡萄糖5.9 mmol/L。
An 8-year-old boy received concomitant treatment with tacrolimus 1. 25 mg every 12 hours and prednisone 12. 5 mg once every other day for idiopathic membranous nephropathy. Five weeks later,the boy developed polydipsia,polyuria,vomiting,somnolence,and dehydration. Laboratory tests showed the following values:fasting plasma glucose 22. 4 mmol/L,blood pH 7. 24,standard bicarbonate 12 mmol/L,and urine ketone bodies( +++). The patient was diagnosed with ketoacidosis. Tacrolimus was stopped and he was treated with fluid supplementation 2 125 ml/d and continuous IV infusion of recombinant human insulin 2. 5 U/h. After 10 hours,laboratory results indicated that blood pH was 7. 40,fasting plasma glucose was 8. 5 mmol/L,and detection of urine ketone was negative for two times in a row. Then,his treatment was switched to subcutaneous injection of recombinant human insulin 6. 25 U before three meals. After 3 weeks,the fasting plasma glucose was 5. 9 mmol/L.
出处
《药物不良反应杂志》
CSCD
2014年第5期304-305,共2页
Adverse Drug Reactions Journal